Skip to main content
Retour
Watch Compare

Biofrontera Inc.

Qualité des données : 100%
Également cotée sous BFRIW NASDAQ
BFRI
NASDAQ Manufacturing Chemicals
1,02 €
▼ 0,02 € (-1,46%)
Cap. Boursière: 12,17 M
Prix
1,05 €
Cap. Boursière
12,17 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 14,69% annually over 5 years — strong growth
Negative free cash flow of -13,36 M
Capital efficient — spends only 0,00% of revenue on capex

Croissance

Revenue Growth (5Y)
14,69%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)11,75%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-540,54%
Net Margin-25,26%
Op. Margin-27,21%

Sécurité

Debt / Equity
N/A
Current Ratio1,15
Interest CoverageN/A

Valorisation

PE (TTM|NTM|2027)
-1,16 | 7,36 | 7,50
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -1,2 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % -25,3 -41,5
Rev Growth 5Y % 14,7 1,8
D/E — 0,3

Objectif de Cours des Analystes

2 analystes
Buy
Actuel
1,02 €
+491.1%
Objectif
6,00 €
3,00 €
6,00 €
9,00 €
Prévisions
P/E Prévisionnel 7,36
BPA Prévisionnel 0,14 €
CA Est. 54,70 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,14 €
0,14 € – 0,14 €
 54,70 M 1
FY2026 -0,06 €
-0,06 € – -0,06 €
 46,76 M 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 0,10 € 0,50 € +398,1%
Q32025 -0,56 € -0,57 € -1,6%
Q22025 -0,39 € -0,57 € -45,1%
Q12025 -0,29 € -0,51 € -75,3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11,75% Revenue Growth (3Y) 10,64%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 14,69% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 41,71 M Net Income (TTM) -10,54 M
ROE N/A ROA -59,26%
Gross Margin N/A Operating Margin -27,21%
Net Margin -25,26% Free Cash Flow (TTM) -13,36 M
ROIC -540,54% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,15
Interest Coverage N/A Asset Turnover 2,35
Working Capital 1,86 M Tangible Book Value -2,60 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,16 Forward P/E 7,36
P/B Ratio N/A P/S Ratio 0,29
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,22 Fwd Earnings Yield 13,59%
FCF Yield -109,78%
Market Cap 12,17 M Enterprise Value 8,76 M
Per Share
EPS (Diluted TTM) -1,04 Revenue / Share 3,58
FCF / Share -1,15 OCF / Share -1,15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 126,83%
SBC-Adj. FCF -14,31 M Growth Momentum -2,94

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 41,71 M 37,32 M 34,07 M 28,67 M 24,10 M
Net Income -10,54 M -17,76 M -20,13 M -640 000,0 -37,71 M
EPS (Diluted) -1,04 -3,22 -13,02 — —
Gross Profit — — — — —
Operating Income -11,35 M -17,21 M -22,68 M -18,58 M -25,20 M
EBITDA — — — — —
R&D Expenses 3,72 M 2,09 M 77 000,0 — —
SG&A Expenses 37,75 M — 38,98 M 35,14 M 36,51 M
D&A 138 000,0 600 000,0 — — —
Interest Expense — — 220 000,0 195 000,0 344 000,0
Income Tax 25 000,0 22 000,0 14 000,0 32 000,0 56 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 28,56 M 22,10 M 27,93 M 50,88 M 53,22 M
Total Liabilities 18,08 M 17,67 M 23,14 M 27,01 M 41,88 M
Shareholders' Equity 10,48 M 4,43 M 4,79 M 23,88 M 11,34 M
Total Debt — 3,90 M 3,90 M — —
Cash & Equivalents 6,39 M 5,91 M 1,34 M 17,21 M 24,55 M
Current Assets 18,08 M 20,70 M 23,08 M 43,14 M 46,42 M
Current Liabilities 11,90 M 12,02 M 18,09 M 20,89 M 13,84 M

Scores de Stratégies

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Value Price/Sales Ratio Focus (Ken Fisher)
#198 of 245
28

Activité Récente

Entré Price/Sales Ratio Focus (Ken Fisher)
Apr 12, 2026